Ixempra (Ixapebilone) – New Cancer Therapy, No Country
Key Data:
Drug (brand/generic)
Ixempra/Ixabepilone
Company/licensee
BMS
Therapy class
Epothilone
Product description
Microtubule inhibitor
Current indication
Metastatic or locally advanced breast cancer
Market sector
Oncology
Development status
Approved in the US
